Hiroji Iwata

40PUBLICATIONS
231CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Epidemiological methodsClinical midwifery
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (40)

|Jun 17, 2026
Prognosis of ER-positive, HER2-negative postmenopausal early breast cancer patients based on response to neoadjuvant endocrine therapy and multigene assay results: findings from the NEOS trial.

|May 18, 2026
Comprehensive Genomic and Transcriptomic Characterization of MTAP Loss across Advanced Solid Tumors.

|Mar 26, 2026
Sacituzumab govitecan in Japanese participants with HR+/HER2- metastatic breast cancer: primary results from the phase II ASCENT-J02 study.

Akihiko Shimomura, Takahiro Kogawa, Koji Matsumoto

|Jan 21, 2026
HER2 Protein Overexpression, mRNA Expression, and DNA Amplification Across Solid Tumors: Comparison of Next-Generation Sequencing-Based Assays With Immunohistochemistry.

Michiko Nagamine, Takao Fujisawa, Naoya Sakamoto

|Jul 09, 2025
Current status and perspective of ctDNA-based MRD testing in breast cancer: a systematic review.

Yukinori Ozaki, Hiroji Iwata

|Jun 02, 2025
Landscape Analysis of CLDN18 Expression and Isoform Distribution in Solid Tumors: Insights From MONSTAR-SCREEN-2 Study.

Tadayoshi Hashimoto, Naoko Iida, Yoshiaki Nakamura

Pageof 7

Frequent Collaborators

6 joint publications

Masataka Sawaki

6 joint publications

Takayuki Yoshino

6 joint publications

Yoshiaki Nakamura

6 joint publications

Masaya Hattori